Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris

References

• AnsteyAVKragballeKRetrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointmentInter J Dermatol2006459705
   PubMed Web of Science ®Google Scholar
• AshcroftDMLi Wan PoAGriffithsCETherapeutic strategies for psoriasisJ Clin Pharm Ther200025210
   Web of Science ®Google Scholar
• BarnaMBosJDKapsenbergMLEffect of calcitriol on the production of T-cell-derived cytokines in psoriasisBr J Dermatol1997136536419155954
   PubMed Web of Science ®Google Scholar
• BeatoMGene regulation by steroid hormonesCell198956335442644044
   PubMed Web of Science ®Google Scholar
• Berth-JonesJChuACDoddWAHA multi-centre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasisBr J Dermatol1992127266711390171
   PubMed Web of Science ®Google Scholar
• BosJDThe pathomechanisms of psoriasis; the skin immune system and cyclosporineBr J Dermatol1988118141553279998
   PubMed Web of Science ®Google Scholar
• BruceSEpinetteWWFunicellaTComparative study of calcipotriol (MC 903) ointment and fluocinonide ointment in the treatment of psoriasisJ Am Acad Dermatol19943175597929921
   PubMed Web of Science ®Google Scholar
• BuryYRufDHansenCMMolecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseasesJ Invest Dermatol20011167859211348471
   PubMed Web of Science ®Google Scholar
• CarrollCLFeldmanSRCamachoFTAdherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual useJ Am Acad Dermatol2004512121615280839
   PubMed Web of Science ®Google Scholar
• CharakidaADadzieOTeixeiraFCalcipotriol/Betamethasone dipropionate for the treatment of psoriasisExpert Opin Pharmacother2006759760616553575
   PubMed Web of Science ®Google Scholar
• ChristophersEPsoriasis-epidemiology and clinical spectrumClin Exp Dermatol2001263142011422182
   PubMed Web of Science ®Google Scholar
• CullenSILong-term effectiveness and safety of topical calcipotriene for psoriasisSouth Med J199689105368903286
   PubMed Web of Science ®Google Scholar
• CunliffeWJBerth-JonesJClaudyAComparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgarisJ Am Acad Dermatol1992265 Pt 1736431583173
   PubMed Web of Science ®Google Scholar
• De JongEMFerrierCMde ZwartAEffects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasisJ Dermatol Sci19959185948664216
   PubMed Web of Science ®Google Scholar
• DouglasWSPoulinYDecroixJA new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgarisActa Derm Venereol200282315
   Web of Science ®Google Scholar
• FentonCPloskerGCalcipotriol/Betamethasone dipropionate: A reviewAm J Clin Dermatol200454637815663344
   PubMed Web of Science ®Google Scholar
• GelfandJMWeinsteinRPorterSBPrevalence and treatment of psoriasis in the United KingdomArch Dermatol200514115374116365254
   PubMed Web of Science ®Google Scholar
• GottliebABPsoriasisDis Manage Clin Outcomes19981195202
   Google Scholar
• GuentherLCambazardFvan de KerkhofPCMEfficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trialBr J Dermatol20021473162312174105
   PubMed Web of Science ®Google Scholar
• GuentherLLangleyRGShearNHIntegrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian psoriasis expert panelJ Cut Med Surg2004832137
   PubMed Web of Science ®Google Scholar
• GuentherLCCalcipotriol/Betamethasone dipropionate: Daivobet/DovobetTherapy2005234348
   Google Scholar
• HansenJMixing the unmixable. Verbal communication at the Leo Satellite Symposium200110th Congress of the European Academy of Dermatology and VenereologyOct 10–14Munich, Germany
   Google Scholar
• JullienDPsoriasis physiopathologyJ Eur Acad Dermatol Venereol200620suppl. 21023
   Web of Science ®Google Scholar
• KaufmannRBibbyAJBissonnetteRA new calcipotriol/betamethasone dipropionate formujlation (Daivobet™) is an effective once daily treatment for psoriasis vulgarisDermatology20022053899312444337
   PubMed Web of Science ®Google Scholar
• KoliKKeski-OjaJVitamin D3 and calcipotriol enhance the secretion of transforming growth factor -beta 1 and -beta 2 in cultured murine keratinocytesGrowth Factors19938153638466756
   PubMed Web of Science ®Google Scholar
• KooJYCurrent consensus and update on psoriasis therapy: a perspective from the U.SJ Dermatol1999267233310635614
   PubMedGoogle Scholar
• KragballeKAustadJBarnesLA 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgarisBr J Dermatol2006a15411556016704648
   PubMed Web of Science ®Google Scholar
• KragballeKAustadJBarnesLEfficacy results of a 52-week randomized double-blind safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgarisDermatology2006b2133192617135738
   PubMed Web of Science ®Google Scholar
• KragballeKGjertsenBde HoopDDouble-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisLancet199133719361670840
   PubMed Web of Science ®Google Scholar
• KragballeKNoerrelundKLLuiHEfficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgarisBr J Dermatol200415011677315214905
   PubMed Web of Science ®Google Scholar
• KragballeKvan de KerkhofPCConsistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasisJ Eur Acad Dermatol Venereol200620394416405606
   PubMed Web of Science ®Google Scholar
• LebwohlMPsoriasisLancet2003361119720412686053
   PubMed Web of Science ®Google Scholar
• MullerKDiamantMBendtzenKInhibition of production and function of interleukin-6 by 1, 25 -dixydroxyvitamin D3 Immunol Lett199128115201885209
   PubMed Web of Science ®Google Scholar
• MullerKSvensonMBendtzenK1 alpha, 25 -Dixydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vivoImmunol Lett19881736153259542
   PubMed Web of Science ®Google Scholar
• OrtonneJPKaufmannRLechaMEfficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomized, double-blind trialDermatology20042093081315539894
   PubMed Web of Science ®Google Scholar
• PappKMelgaardAPooled safety data for a calcipotriene/betamethasone dipropionate two-compound product in the treatment of psoriasis vulgarisJ Am Acad Dermatol2007562, Suppl. 2AB183
   Web of Science ®Google Scholar
• PappKAGuentherLBoydenBEarly onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasisJ Am Acad Dermatol200348485412522370
   PubMed Web of Science ®Google Scholar
• ParslewRTraulsenJEfficacy and local safety of a calcipotriol/betamethasone dipropionate ointment in elderly patients with psoriasis vulgarisEur J Dermatol20051537915701591
   PubMed Web of Science ®Google Scholar
• PeetersPOrtonneJPSitbonRCost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgarisDermatology20052111394516088161
   PubMed Web of Science ®Google Scholar
• PeetersPOrtonneJPSitbonRCost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of psoriasis vulgarisDermatology20052111394516088161
   PubMed Web of Science ®Google Scholar
• PlunkettAMarksRA review of the epidemiology of psoriasis vulgaris in the communityAustralas J Dermatol199839225329838718
   PubMedGoogle Scholar
• RichardsHLFortuneDGPsychological distress and adherence in patients with psoriasisJ Eur Acad Dermatol Venereol200620suppl 23341
   Web of Science ®Google Scholar
• RogersCCalcipotriol (Dovobet®) ointment in combination with UVB therapy for psoriasis treatmentDermatol Nurs2006182586116856679
   PubMedGoogle Scholar
• SchönMPBoehnckeWHPsoriasisN Engl J Med2005352189991215872205
   PubMed Web of Science ®Google Scholar
• SimonsenLHoyGDidriksenEDevelopment of a new formulation combining calcipotriol and betamethasone dipropionate in an ointment vehicleDrug Dev Ind Pharm200430109510215595576
   PubMed Web of Science ®Google Scholar
• SinghSReddyDCSPandeySSTopical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeksJ Am Acad Dermatol20004361710863225
   PubMed Web of Science ®Google Scholar
• SterryWBarkerJBoehnckeWHBiological therapies in the systemic management of psoriasis: International Consensus ConferenceBr J Dermatol2004151Suppl 6931715265063
   PubMed Web of Science ®Google Scholar
• SwanbeckGInerotAMartinssonTAge at onset and different types of psoriasisBr J Dermatol1995133768738555031
   PubMed Web of Science ®Google Scholar
• TagamiHAibaSBosJDPsoriasisSkin Immune System (SIS)19972Boca Raton, New YorkCRC Press LLC523530
   Google Scholar
• ThamSNLunKCCheongWKA comparative study of calcipotriene ointment and tar in chronic plaque psoriasisBr J Dermatol199413167377999599
   PubMed Web of Science ®Google Scholar
• TraulsenJHughes-FormellaBJThe atrophogenic potential and dermal tolerance of calcipotriene/betamethasone dipropionate oinment compared with betamethasone dipropionate ointmentDermatology20032071667212920367
   PubMed Web of Science ®Google Scholar
• TraulsenJBioavailability of betamethasone dipropionate when combined with calcipotriolInt J Dermatol2004436111715304191
   PubMed Web of Science ®Google Scholar
• van de KerkhofPCVissersWHThe topical treatment of psoriasisSkin Pharmacol Appl Skin Physiol200316698312637782
   PubMedGoogle Scholar
• van de KerkhofPCWaselNKragballeKA two compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severityDermatology2005210294915942215
   PubMed Web of Science ®Google Scholar
• van de KerkhofPCKragballeKAustadJPsoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severityEur J Dermatol2006161677116581570
   PubMed Web of Science ®Google Scholar
• van de KerkhofPCBiological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanismsBr J Dermatol1995132675827772470
   PubMed Web of Science ®Google Scholar
• van de KerkhofPCIn vivo effects of vitamin D3 analoguesJ Dermatol Treat19989Suppl. 3S259
   Google Scholar
• van de KerkhofPCThe impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet®/Dovobet®) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trialBr J Dermatol2004151663815377355
   PubMed Web of Science ®Google Scholar
• Van RossumMMvan ErpPEJvan de KerkhopfPCTreatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric studyDermatology20012031485211586014
   PubMed Web of Science ®Google Scholar
• VissersWHBerendsMMuysLThe effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subset in chronic plaque psoriasisExp Dermatol2004131061215009104
   PubMed Web of Science ®Google Scholar
• WhiteSVenderRThaçiDUse of calcipotriene cream (Daivonex®/Dovonex® cream) following acute treatment of psoriasis vulgaris with the alcipotriene/betamethasone dipropionate two-compound product (Daivobet®/Dovobet®): a randomized, parallel-group clinical trialAm J Clin Dermatol200671778416734505
   PubMed Web of Science ®Google Scholar
• WissinkSvan HeerdeECvan DerBBA dual mechanism mediates repression of NF-KAPPAB activity by glucocorticoidsMol Endocrinol199812255363
   Google Scholar